Breaking news:
PM Modi Emphasizes Harmony in Eid Greetings, Rahul Gandhi Calls for Peace | Four Chinese Men Detained After Fleeing Bangkok Collapse Site With Documents | PM Modi Makes First Visit to RSS Headquarters Since Taking Office | Trump Says He’s Seriously Considering a Third Term
Logo

Elon Musk Drops Lawsuit Against OpenAI Amidst Ongoing Dispute

Elon Musk's decision to withdraw his lawsuit against OpenAI follows a series of criticisms and disputes over the company's direction and partnership with Apple, shedding light on the complex dynamics between Musk and the AI organization 

12-06-2024
image
   

After months of legal wrangling, Tesla CEO Elon Musk has withdrawn his lawsuit against OpenAI, the organization behind the development of ChatGPT.

The lawsuit, filed in February, accused OpenAI of breaching its contract and engaging in unfair business practices. Musk alleged that the organization's focus on profit maximization, particularly through its partnership with Microsoft, contradicted its original mission of serving humanity.

Despite the dismissal, Musk retains the option to refile the lawsuit at a later date. The withdrawal comes shortly after Musk publicly criticized OpenAI's collaboration with Apple, raising questions about the relationship between the two tech giants.

OpenAI, in response, refuted Musk's claims and released old emails suggesting his previous support for the organization's for-profit endeavors. The legal dispute underscores the complexities of tech partnerships and the challenges of balancing commercial interests with ethical responsibilities.

Image

IndiGo Slapped with Rs 944 Crore Tax Penalty, Vows Legal Battle

InterGlobe Aviation, the parent company of IndiGo, has been hit with a ₹944.20 crore penalty by th

Read More
Image

Sam Altman Urges Users to Slow Down as AI-Generated Ghibli Trend Overloads Ch

OpenAI CEO Sam Altman asked users to ease up on AI-generated images after an internet frenzy over Gh

Read More
Image

Prices of Government-Regulated Medicines Set to Rise by 1.7%

The cost of essential medicines, including those for cancer, diabetes, heart conditions, and antibio

Read More